Treatment Options for Irritable Bowel Syndrome with Diarrhea (IBS-D)
For patients with IBS-D, a structured approach starting with first-line dietary and lifestyle modifications followed by pharmacological interventions targeting predominant symptoms offers the most effective management strategy, with 5-HT3 receptor antagonists being the most efficacious drug class for IBS-D. 1
First-Line Treatments
Lifestyle Modifications
- Regular exercise should be advised for all patients with IBS-D as it can improve symptoms 1
- First-line dietary advice should be offered to all patients 1
Dietary Approaches
- Soluble fiber (e.g., ispaghula) is effective for global symptoms and abdominal pain, starting at low doses (3-4g/day) and gradually increasing to avoid bloating 1
- Low FODMAP diet can be considered as second-line dietary therapy, but should be supervised by a trained dietitian with planned reintroduction of FODMAPs according to tolerance 1
- Food elimination diets based on IgG antibodies are not recommended 1
- Gluten-free diets are not recommended specifically for IBS 1
Over-the-Counter Options
- Loperamide is effective for diarrhea management but may cause abdominal pain, bloating, nausea, and constipation; careful dose titration is recommended 1
- Certain antispasmodics may help with global symptoms and abdominal pain, though side effects include dry mouth, visual disturbance, and dizziness 1
- Probiotics may be effective for global symptoms and abdominal pain, but no specific strain can be recommended; a 12-week trial is reasonable 1
Second-Line Treatments
Gut-Brain Neuromodulators
- Tricyclic antidepressants (TCAs) are effective second-line treatments for global symptoms and abdominal pain 1
- Selective serotonin reuptake inhibitors (SSRIs) may be effective for global symptoms 1
- Consider particularly when concurrent mood disorders are present 1
IBS-D Specific Medications
5-HT3 receptor antagonists are the most efficacious drug class for IBS-D 1
- Alosetron is effective but restricted to women with severe IBS-D under a risk management program due to rare but serious adverse events including ischemic colitis 1
- Ondansetron (4mg once daily, titrated to maximum 8mg three times daily) is a reasonable alternative where alosetron is unavailable 1
- Constipation is the most common side effect 1
Eluxadoline (mixed opioid receptor drug) is efficacious for IBS-D 1, 2
Rifaximin (non-absorbable antibiotic) is effective for IBS-D 1, 3
Other Considerations
- Bile acid sequestrants (e.g., cholestyramine) may be considered for patients with cholecystectomy or suspected bile acid malabsorption 1
- Psychological therapies (cognitive behavioral therapy, hypnotherapy) can be effective for global symptoms and abdominal pain 1
- Consider these approaches when symptoms are refractory to drug treatment for 12 months 1
Treatment Algorithm
- Start with lifestyle modifications and dietary advice 1
- For diarrhea control: Loperamide with careful dose titration 1
- If inadequate response, add antispasmodics for pain and bloating 1
- For persistent symptoms, consider second-line therapies:
- For refractory symptoms: Consider psychological therapies 1
Common Pitfalls and Caveats
- Avoid insoluble fiber (e.g., wheat bran) as it may worsen symptoms 1
- When using TCAs, start at low doses and titrate slowly to minimize side effects 1
- Carefully screen patients before prescribing eluxadoline due to contraindications 1
- Rifaximin is not effective for travelers' diarrhea caused by pathogens other than E. coli 3
- Alosetron should only be used in women with severe IBS-D under risk management protocols due to risk of ischemic colitis 1